NR1H4 and metabolic dysfunction-associated steatohepatitis: Because Fincor is induced specifically by the hammerhead class of FXR agonist (Figure 4) and has a potential role in the regulation of metabolism and inflammation (Figure 5), we hypothesized that Fincor may play a role in tropifexor-mediated beneficial effects on reducing NASH pathologies in mice.